267 related articles for article (PubMed ID: 18358709)
1. GATA-3 and the regulation of the mammary luminal cell fate.
Kouros-Mehr H; Kim JW; Bechis SK; Werb Z
Curr Opin Cell Biol; 2008 Apr; 20(2):164-70. PubMed ID: 18358709
[TBL] [Abstract][Full Text] [Related]
2. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.
Kouros-Mehr H; Slorach EM; Sternlicht MD; Werb Z
Cell; 2006 Dec; 127(5):1041-55. PubMed ID: 17129787
[TBL] [Abstract][Full Text] [Related]
3. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
[TBL] [Abstract][Full Text] [Related]
4. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation.
Asselin-Labat ML; Sutherland KD; Barker H; Thomas R; Shackleton M; Forrest NC; Hartley L; Robb L; Grosveld FG; van der Wees J; Lindeman GJ; Visvader JE
Nat Cell Biol; 2007 Feb; 9(2):201-9. PubMed ID: 17187062
[TBL] [Abstract][Full Text] [Related]
5. GATA3 in development and cancer differentiation: cells GATA have it!
Chou J; Provot S; Werb Z
J Cell Physiol; 2010 Jan; 222(1):42-9. PubMed ID: 19798694
[TBL] [Abstract][Full Text] [Related]
6. GATA-3 as a marker of hormone response in breast cancer.
Fang SH; Chen Y; Weigel RJ
J Surg Res; 2009 Dec; 157(2):290-5. PubMed ID: 19059610
[TBL] [Abstract][Full Text] [Related]
7. Developmental biology: cell fate in the mammary gland.
Tong Q; Hotamisligil GS
Nature; 2007 Feb; 445(7129):724-6. PubMed ID: 17301782
[No Abstract] [Full Text] [Related]
8. FoxM1 regulates mammary luminal cell fate.
Carr JR; Kiefer MM; Park HJ; Li J; Wang Z; Fontanarosa J; DeWaal D; Kopanja D; Benevolenskaya EV; Guzman G; Raychaudhuri P
Cell Rep; 2012 Jun; 1(6):715-29. PubMed ID: 22813746
[TBL] [Abstract][Full Text] [Related]
9. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model.
Kouros-Mehr H; Bechis SK; Slorach EM; Littlepage LE; Egeblad M; Ewald AJ; Pai SY; Ho IC; Werb Z
Cancer Cell; 2008 Feb; 13(2):141-52. PubMed ID: 18242514
[TBL] [Abstract][Full Text] [Related]
10. The Stat6-regulated KRAB domain zinc finger protein Zfp157 regulates the balance of lineages in mammary glands and compensates for loss of Gata-3.
Oliver CH; Khaled WT; Frend H; Nichols J; Watson CJ
Genes Dev; 2012 May; 26(10):1086-97. PubMed ID: 22588720
[TBL] [Abstract][Full Text] [Related]
11. Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.
Chen JQ; Bao Y; Litton J; Xiao L; Zhang HZ; Warneke CL; Wu Y; Shen X; Wu S; Katz RL; Sahin A; Bondy M; Murray JL; Radvanyi L
Horm Cancer; 2011 Apr; 2(2):132-43. PubMed ID: 21761336
[TBL] [Abstract][Full Text] [Related]
12. Gata-3 and mammary cell fate.
Naylor MJ; Ormandy CJ
Breast Cancer Res; 2007; 9(2):302. PubMed ID: 17381824
[TBL] [Abstract][Full Text] [Related]
13. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.
Pei XH; Bai F; Smith MD; Usary J; Fan C; Pai SY; Ho IC; Perou CM; Xiong Y
Cancer Cell; 2009 May; 15(5):389-401. PubMed ID: 19411068
[TBL] [Abstract][Full Text] [Related]
14. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate.
Kendrick H; Regan JL; Magnay FA; Grigoriadis A; Mitsopoulos C; Zvelebil M; Smalley MJ
BMC Genomics; 2008 Dec; 9():591. PubMed ID: 19063729
[TBL] [Abstract][Full Text] [Related]
16. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
Voduc D; Cheang M; Nielsen T
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):365-73. PubMed ID: 18268121
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.
Raap M; Gierendt L; Werlein C; Kuehnle E; Kreipe HH; Christgen M
J Mol Histol; 2021 Dec; 52(6):1257-1264. PubMed ID: 34117603
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
19. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
[TBL] [Abstract][Full Text] [Related]
20. Cell lineage determinants as regulators of breast cancer metastasis.
Lu W; Kang Y
Cancer Metastasis Rev; 2016 Dec; 35(4):631-644. PubMed ID: 27866304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
